News | April 22, 2024
Evotech and Variant Bio partner to develop fibrosis treatment
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
AIIMS Rewari is a 750-bed hospital complex which includes a 100 seat medical college, a 60 seat nursing college, a 30-bed AYUSH block
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
Medway setup a state-of-the-art Heart Institute in Chennai
Total transaction value of the divestment is Rs. 3,660 million
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
